The future of therapy for childhood rhabdomyosarcoma: Clues from molecular biology
Open Access
- 15 July 1995
- journal article
- editorial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (4) , 1245-1249
- https://doi.org/10.1016/0360-3016(95)00237-s
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hyperfractionated radiation in children with rhabdomyosarcoma—Results of an intergroup rhabdomyosarcoma pilot studyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The Third Intergroup Rhabdomyosarcoma Study.Journal of Clinical Oncology, 1995
- The Genetic Basis of CancerScientific American, 1995
- Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.Journal of Clinical Investigation, 1994
- Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.Genes & Development, 1993
- Common Solid Tumors of ChildhoodNew England Journal of Medicine, 1991
- N‐myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMSInternational Journal of Cancer, 1990
- Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.Journal of Clinical Oncology, 1990
- N-and c-myc Oncogenes in Childhood RhabdomyosarcomaJNCI Journal of the National Cancer Institute, 1990
- Rhabdomyosarcoma of head and neck in childrenCancer, 1973